BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 28314265)

  • 1. Next-generation Sequencing for microRNA Profiling: MicroRNA-21-3p Promotes Oral Cancer Metastasis.
    Tseng HH; Tseng YK; You JJ; Kang BH; Wang TH; Yang CM; Chen HC; Liou HH; Liu PF; Ger LP; Tsai KW
    Anticancer Res; 2017 Mar; 37(3):1059-1066. PubMed ID: 28314265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism.
    Manikandan M; Deva Magendhra Rao AK; Arunkumar G; Manickavasagam M; Rajkumar KS; Rajaraman R; Munirajan AK
    Mol Cancer; 2016 Apr; 15():28. PubMed ID: 27056547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating miRNAs as biomarkers for oral squamous cell carcinoma recurrence in operated patients.
    Yan Y; Wang X; Venø MT; Bakholdt V; Sørensen JA; Krogdahl A; Sun Z; Gao S; Kjems J
    Oncotarget; 2017 Jan; 8(5):8206-8214. PubMed ID: 28030794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-376c-3p regulates the proliferation, invasion, migration, cell cycle and apoptosis of human oral squamous cancer cells by suppressing HOXB7.
    Wang K; Jin J; Ma T; Zhai H
    Biomed Pharmacother; 2017 Jul; 91():517-525. PubMed ID: 28482289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-133a-3p Inhibits Oral Squamous Cell Carcinoma (OSCC) Proliferation and Invasion by Suppressing COL1A1.
    He B; Lin X; Tian F; Yu W; Qiao B
    J Cell Biochem; 2018 Jan; 119(1):338-346. PubMed ID: 28569392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-200c-3p spreads invasive capacity in human oral squamous cell carcinoma microenvironment.
    Kawakubo-Yasukochi T; Morioka M; Hazekawa M; Yasukochi A; Nishinakagawa T; Ono K; Kawano S; Nakamura S; Nakashima M
    Mol Carcinog; 2018 Feb; 57(2):295-302. PubMed ID: 28981169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-223-3p inhibits proliferation and metastasis of oral squamous cell carcinoma by targeting SHOX2.
    Sun C; Liu XH; Sun YR
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6927-6934. PubMed ID: 31486492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salivary extracellular vesicle-associated miRNAs as potential biomarkers in oral squamous cell carcinoma.
    Gai C; Camussi F; Broccoletti R; Gambino A; Cabras M; Molinaro L; Carossa S; Camussi G; Arduino PG
    BMC Cancer; 2018 Apr; 18(1):439. PubMed ID: 29669525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-216a inhibits the growth and metastasis of oral squamous cell carcinoma by targeting eukaryotic translation initiation factor 4B.
    Li L; Ma HQ
    Mol Med Rep; 2015 Aug; 12(2):3156-62. PubMed ID: 25955794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-204-5p regulates cell proliferation and metastasis through inhibiting CXCR4 expression in OSCC.
    Wang X; Li F; Zhou X
    Biomed Pharmacother; 2016 Aug; 82():202-7. PubMed ID: 27470356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. microRNA-188 is downregulated in oral squamous cell carcinoma and inhibits proliferation and invasion by targeting SIX1.
    Wang L; Liu H
    Tumour Biol; 2016 Mar; 37(3):4105-13. PubMed ID: 26490981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential involvement of miR-375 in the premalignant progression of oral squamous cell carcinoma mediated via transcription factor KLF5.
    Shi W; Yang J; Li S; Shan X; Liu X; Hua H; Zhao C; Feng Z; Cai Z; Zhang L; Zhou D
    Oncotarget; 2015 Nov; 6(37):40172-85. PubMed ID: 26474386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA HOXA11-AS Promotes Proliferation and Cisplatin Resistance of Oral Squamous Cell Carcinoma by Suppression of miR-214-3p Expression.
    Wang X; Li H; Shi J
    Biomed Res Int; 2019; 2019():8645153. PubMed ID: 31275988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNA OIP5-AS1 promotes the progression of oral squamous cell carcinoma via regulating miR-338-3p/NRP1 axis.
    Li M; Ning J; Li Z; Fei Q; Zhao C; Ge Y; Wang L
    Biomed Pharmacother; 2019 Oct; 118():109259. PubMed ID: 31369989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of miR-155 promotes the proliferation and invasion of oral squamous carcinoma cells by regulating BCL6/cyclin D2.
    Zeng Q; Tao X; Huang F; Wu T; Wang J; Jiang X; Kuang Z; Cheng B
    Int J Mol Med; 2016 May; 37(5):1274-80. PubMed ID: 26986233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-361-3p is a potent therapeutic target for oral squamous cell carcinoma.
    Ogawa H; Nakashiro KI; Tokuzen N; Kuribayashi N; Goda H; Uchida D
    Cancer Sci; 2020 May; 111(5):1645-1651. PubMed ID: 32086979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Connective tissue growth factor modulates oral squamous cell carcinoma invasion by activating a miR-504/FOXP1 signalling.
    Yang MH; Lin BR; Chang CH; Chen ST; Lin SK; Kuo MY; Jeng YM; Kuo ML; Chang CC
    Oncogene; 2012 May; 31(19):2401-11. PubMed ID: 21927029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-155-5p is associated with oral squamous cell carcinoma metastasis and poor prognosis.
    Baba O; Hasegawa S; Nagai H; Uchida F; Yamatoji M; Kanno NI; Yamagata K; Sakai S; Yanagawa T; Bukawa H
    J Oral Pathol Med; 2016 Apr; 45(4):248-55. PubMed ID: 26307116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA expression signature of oral squamous cell carcinoma: functional role of microRNA-26a/b in the modulation of novel cancer pathways.
    Fukumoto I; Hanazawa T; Kinoshita T; Kikkawa N; Koshizuka K; Goto Y; Nishikawa R; Chiyomaru T; Enokida H; Nakagawa M; Okamoto Y; Seki N
    Br J Cancer; 2015 Mar; 112(5):891-900. PubMed ID: 25668004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-127-3p targets KIF3B to inhibit the development of oral squamous cell carcinoma.
    Ji L; Zhu ZN; He CJ; Shen X
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):630-640. PubMed ID: 30720171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.